A quantitative assessment of sleep laboratory activity in the United States.

Division of Sleep Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.
Journal of clinical sleep medicine: JCSM: official publication of the American Academy of Sleep Medicine (Impact Factor: 2.83). 02/2005; 1(1):23-6.
Source: PubMed

ABSTRACT To determine the total number of active sleep laboratories in the United States and the number of polysomnograms conducted on a yearly basis in these laboratories.
All members of the AASM and all AASM accredited sleep laboratory directors received a questionnaire addressing their laboratory and its volume. In three states, multiple telephone calls to AASM members were used to correctly identify the absolute number of labs and their PSG volume in those states. Extrapolating from the number of labs studies identified per questionnaire relative to the correct number (per calls) in those states and, then applying this ratio to the entire US, the total number of labs and studies was determined.
Our data suggests that there are, in the year 2001, 1,292 sleep laboratories conducting 1,165,135 polysomnograms per year. This comes to 427 PSG's/year per 100,000 population in the United States.
These data suggest that there are a relatively large number of sleep laboratories in the US conducting a substantial number of PSG's. However, there was considerable variability in this volume between states that did not relate to known markers of healthcare utilization. These numbers have likely increased since 2001.


Available from: Naoko Tachibana, May 15, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This paper presents a shirt embedded with simple capacitive sensors that accurately monitors the respiration of a sleeping person through chest expansion. It will also discuss a software package that, when coupled with this device, can determine sleep stages from the acquired data. Current sleep studies are the only medically accepted form of sleep health detection and diagnosis; due to the relatively high price of these studies, only persons with breathing-related disorders are referred to them. These studies depend on polysomnography, the use of various bodily signals for sleep detection; patients are often connected to over twenty sensors ranging from brain wave electrodes to blood oxygen trackers. The Somnus shirt is a comfortable, low-cost solution that could be used in the patient's regular sleep setting. Through some preliminary testing, our respiration-monitoring prototype was able to produce respiration data similar to that of sensors employed in current sleep labs while achieving a higher level of comfort for the user; also, the software package was able to analyze sleep with accuracy comparable to current sleep laboratory technicians.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Increasing awareness of the high prevalence of obstructive sleep apnea (OSA) and its impact on health in conjunction with high cost, inconvenience, and short supply of in-lab polysomnography (PSG) has led to the development of more convenient, affordable, and accessible diagnostic devices. We evaluated the reliability and accuracy of a single-channel (finger pulse-oximetry) photoplethysmography (PPG)-based device for detection of OSA (Morpheus Ox). Among a cohort of 73 patients referred for in-laboratory evaluation of OSA, 65 were simultaneously monitored with the PPG based device while undergoing PSG. Among these, 19 had significant cardiopulmonary comorbidities. Using the PSG as the "gold standard," the sensitivity, specificity, negative predictive value (NPV), positive predictive value (PPV), as well as the positive likelihood ratio (+LR) for an apnea hypopnea index (AHI)PSG > 5/h and AHIPSG > 15/h were calculated for the PPG. Valid results were available for 65 subjects. Mean age: 52.1 ± 14.2, Male: 52%, and BMI: 36.3 ± 9.7 kg/m(2). Positive correlation was found between PPG-derived and PSG-derived AHI (r = 0.81, p < 0.001). For AHIPSG > 5/h, sensitivity was 80%, specificity 86%, PPV 93%, NPV 68%, and +LR was 5.9. For AHIPSG > 15/h, sensitivity was 70%, specificity 91%, PPV 80%, NPV 85%, and +LR was 7.83. The corresponding areas under the receiver operator curves were 0.91 and 0.9. PPG-derived data compare well with simultaneous in-lab PSG in the diagnosis of suspected OSA among patients with and without cardiopulmonary comorbidities. Romem A; Romem A; Koldobskiy D; Scharf SM. Diagnosis of obstructive sleep apnea using pulse oximeter derived photoplethysmographic signals. J Clin Sleep Med 2014;10(3):285-290.
    Journal of clinical sleep medicine: JCSM: official publication of the American Academy of Sleep Medicine 01/2014; 10(3):285-90. DOI:10.5664/jcsm.3530 · 2.83 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Rationale: Over a million polysomnograms (PSGs) are performed annually in the United States to diagnose obstructive sleep apnea (OSA). Third party payers now advocate a home sleep test (HST), rather than an in-laboratory PSG, as the diagnostic study for OSA regardless of clinical probability but the economic benefit of this approach is not known. Objectives: We determined the diagnostic performance of OSA prediction tools including the newly developed OSUNet, based on artificial neural network, and performed a cost-minimization analysis when the prediction tools are used to identify patients who should undergo HST. Methods: The OSUNet was trained to predict the presence of OSA in a derivation group of patients who underwent an in-laboratory PSG (n=383). Validation group 1 consisted of in-laboratory PSG patients (n=149). The network was trained further in 33 patients who underwent HST and then validated in a separate group of 100 HST patients (validation group 2). Likelihood ratios (LRs) were compared to two previously published prediction tools. The total costs from the use of the three prediction tools and the third party approach within a clinical algorithm were compared. Measurements and Main Results: The OSUNet had higher +LR in all groups compared to the STOP-BANG and the Modified Neck Circumference (MNC) prediction tools. The +LRs for STOP-BANG, MNC, and OSUNet in validation group 1 were: 1.1 [1.0-1.2], 1.3 [1.1-1.5], and 2.1 [1.4-3.1]; and in validation group 2 they were: 1.4 [1.1; 1.7], 1.7 ([1.3-; 2.2], and 3.4 [1.8-6.1], respectively. With an OSA prevalence of <52%, the use of all three clinical prediction tools resulted in cost savings compared to the third party approach. Conclusions: The routine requirement of a HST to diagnose OSA regardless of clinical probability is more costly compared to the use of OSA clinical prediction tools that identify patients who should undergo this procedure when OSA is expected to be present in less than half of the population. With OSA prevalence less than 40%, the OSUNet offers the greatest savings which are substantial when the number of sleep studies done annually is considered.
    07/2014; DOI:10.1513/AnnalsATS.201404-161OC